Transcutaneous Electrical Stimulation Aids Gastroesophageal Reflux Disease
By Lori Solomon HealthDay Reporter
TUESDAY, Feb. 4, 2025 -- A transcutaneous electrical stimulation system (TESS) is effective in reducing both symptoms and esophageal acid exposure time in patients with gastroesophageal reflux disease (GERD), according to a study published online Jan. 23 in Neurogastroenterology & Motility.
Ram Dickman, M.D., from the Rabin Medical Center in Petah Tikva, Israel, and colleagues assessed the effect of TESS on GERD symptoms and acid exposure time. The analysis included 26 patients who had increased acid exposure time (percent total time pH <4 above 6 percent) and who were treated for up to three weeks with TESS.
The researchers found the mean numbers of daily heartburn and regurgitation episodes were 2.55 and 1.40, respectively, which dropped to 0.77 and 0.36, respectively, following TESS. At baseline, mean acid exposure time and DeMeester score were 12.4 and 32.1, respectively, which dropped to 6.0 and 16.2, respectively, following TESS.
"In summary, TESS appears to be safe and effective in reducing esophageal acid exposure and improving heartburn and regurgitation in GERD patients," the authors write. "A larger prospective, sham-controlled study is currently designed to verify these early results."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Lower Rates of Symptom Rebound Seen After H. Pylori Eradication in GERD
THURSDAY, March 6, 2025 -- For patients with gastroesophageal reflux disease (GERD), those with Helicobacter pylori infection have significantly lower rates of symptom rebound and...
Fecal Microbiota Transplant Beneficial in T1DM With Bowel Symptoms
MONDAY, Jan. 13, 2025 -- For patients with type 1 diabetes with moderate-to-severe gastrointestinal symptoms, fecal microbiota transplantation (FMT) is safe and improves clinical...
Tinnitus Risk Increased for Patients With Gastroesophageal Reflux Disease
FRIDAY, Jan. 3, 2025 -- Patients with gastroesophageal reflux disease (GERD) have an increased risk for tinnitus, according to a study published online Dec. 3 in Scientific...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.